Enzon Pharmaceuticals, Inc. (ENZN) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Enzon Pharmaceuticals, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Investment Score:
64/100
Moderate
Valuation Metrics
P/E Ratio
14.89
Weak
WeakModerateStrong
P/B Ratio
3.85
Strong
WeakModerateStrong
Earnings Yield
6.72%
Strong
WeakModerateStrong
Profitability Health
Return on Equity
25.86%
Strong
WeakModerateStrong
Operating Margin
-5103.85%
Weak
WeakModerateStrong
Net Profit Margin
2992.31%
Strong
WeakModerateStrong
Growth Indicators
Revenue Growth
N/A%
Net Income Growth
693.88%
Strong
WeakModerateStrong
EPS Growth
-615.38%
Weak
WeakModerateStrong
Efficiency & Liquidity
Current Ratio
28.10
Strong
WeakModerateStrong
Quick Ratio
28.10
Strong
WeakModerateStrong
Asset Turnover
0.00x
Weak
WeakModerateStrong
Inventory Turnover
0.00x
Weak
WeakModerateStrong